Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis

被引:38
作者
Haspel, HC
Scicli, GM
McMahon, G
Scicli, AG
机构
[1] Henry Ford Hlth Syst, Dept Anesthesiol, Detroit, MI 48202 USA
[2] Henry Ford Hlth Syst, Dept Eye Care Serv, Detroit, MI 48202 USA
[3] SUGEN Inc, San Francisco, CA USA
关键词
CD31; Flk-1; Flt-1; PECAM-1;
D O I
10.1006/mvre.2001.2383
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The angiogenic vascular endothelial growth factor (VEGF) is believed to play a critical role in endothelial cell proliferation, differentiation, and sprouting. Small molecules that selectively inhibit the VEGF receptor-associated tyrosine kinase activities of Flk-1 (KDR) and Flt-1 have been developed. These agents, a prototype being SU5416, have effects on the proliferation of cultured endothelial cells, constrain angiogenesis in vivo, and have been proposed as antitumor drugs. Although SU5416 inhibits in vivo angiogenesis, it is not clear which of the complex processes leading to angiogencsis are impacted by VEGF receptor-associated tyrosine kinase inhibition. We utilized SU5416 and a microvascular endothelial cell line derived from mouse heart (SMHEC4) to specifically examine the role of VEGF receptor-associated tyrosine kinase activity on in vitro models of angiogenesis. We characterized spheroid formation and sprouting, a new model of angiogenesis, in this stable cell line. SU5416 inhibits (similar to50%) VEGF (50 ng/ml) stimulated and basal DNA synthesis, of SMHEC4 cultured in monolayer. SU5416 does not prevent the aggregation and organization of SMHEC4 into tri-dimensional spheroids. CD31, a marker of differentiated endothelial cells, is negligibly expressed in monolayer cultures but highly expressed in SMHEC4 spheroids. The content and biochemical characteristics of spheroidal CD31 are unaltered by SU5416. SU5416 also does not prevent the spontaneous and rapid (similar to3-h) alignment into cords by SMHEC4 on Matrigel. These two models suggest that the organization and differentiation of endothelial cells is independent of VEGF receptor-associated tyrosine kinase signaling. SMHEC4 spheroids embedded in collagen gels spontaneously and rapidly (similar to6 h) sprout capillary-like projections and subsequently (1-2 days) form complex self-anastomosing networks. In addition, VEGF (50 ng/ml) markedly stimulates sprouting of capillary-like projections from SMHEC4 spheroids. Both the spontaneous and the VEGF-stimulated sprouting are nearly eliminated by SU5416. This demonstrates that VEGF receptor-associated tyrosine kinase activity is essential to the formation of capillary-like structures from SMHEC4 spheroids. Overall, these observations demonstrate that (a) the spheroid sprouting model is appropriate for the study of angiogenesis since it appears to recapitulate many of its steps and (b) SU5416 can inhibit endothelial cell proliferation and sprouting without impacting the organization and differentiation of endothelial cells. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:304 / 315
页数:12
相关论文
共 30 条
[1]   Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium - A study of aortic and microvascular endothelial cell lines [J].
Bastaki, M ;
Nelli, EE ;
DellEra, P ;
Rusnati, M ;
MolinariTosatti, MP ;
Parolini, S ;
Auerbach, R ;
Ruco, LP ;
Possati, L ;
Presta, M .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (03) :454-464
[2]   PHENOTYPIC MODULATIONS OF HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS AND HUMAN DERMAL FIBROBLASTS USING 2 ANGIOGENIC ASSAYS [J].
BIKFALVI, A ;
CRAMER, EM ;
TENZA, D ;
TOBELEM, G .
BIOLOGY OF THE CELL, 1991, 72 (03) :275-278
[3]   New paradigms for the treatment of cancer: The role of anti-angiogenesis agents [J].
Cherrington, JM ;
Strawn, LM ;
Shawver, LK .
ADVANCES IN CANCER RESEARCH, VOL 79, 2000, 79 :1-38
[4]   Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis [J].
Claffey, KP ;
Abrams, K ;
Shih, SC ;
Brown, LF ;
Mullen, A ;
Keough, M .
LABORATORY INVESTIGATION, 2001, 81 (01) :61-75
[5]  
DeLisser HM, 1997, AM J PATHOL, V151, P671
[6]   Thrombin-induced association of SHP-2 with multiple tyrosine-phosphorylated proteins in human platelets [J].
Edmead, CE ;
Crosby, DA ;
Southcott, M ;
Poole, AW .
FEBS LETTERS, 1999, 459 (01) :27-32
[7]  
Fong TAT, 1999, CANCER RES, V59, P99
[8]   Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development [J].
Gale, NW ;
Yancopoulos, GD .
GENES & DEVELOPMENT, 1999, 13 (09) :1055-1066
[9]  
GOLDBERGER A, 1994, J BIOL CHEM, V269, P17183
[10]  
GUMKOWSKI F, 1987, BLOOD VESSELS, V24, P11